The rationale for this selection is the fact that endometrial cancer has been strongly correlated with obesity and diabetes and, furthermore, seems to be affected by circulating insulin/IGF1 levels. This evidence concerns the gene IGF1 and obesity due to melanocortin 4 receptor deficiency.